YIH
LKFT

Y-Intercept (HK)’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Y-Intercept (HK)’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,690
Closed -$208K – 1309
2022
Q4 		$208K Buy
+4,690
New +$197K 0.03% 818

Other funds holding LKFT

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Y-Intercept (HK)'s LKFT Position: Q1 2023 in Review

Y-Intercept (HK) sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2023, closing a stake of 4,690 shares — an estimated $208K sold.

Y-Intercept (HK) first reported a position in LKFT in Q4 2022 and held it in 1 quarter. The position peaked at $208K in Q4 2022. 75 funds tracked by Wall St. Rank hold LKFT as of Q1 2023.

  • Y-Intercept (HK) reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • Y-Intercept (HK) sold 4,690 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2023, an estimated $208K.
  • Y-Intercept (HK) first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2022 and held it in 1 quarter.
  • Y-Intercept (HK)'s Lakefront Biotherapeutics American Depositary Shares position peaked at $208K in Q4 2022.
  • 75 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2023.

Based on Y-Intercept (HK)'s 13F filing for Q1 2023, filed 9 May 2023.